Table 1.
Percentage of resistant Enterococcus strains to indicator antibiotics from inpatient and outpatient departments (2008–2017).
| 2008–2012 | 2013–2017 | |||||
|---|---|---|---|---|---|---|
| Outpatients (%) | Inpatients (%) | Statisticsa | Outpatients (%) | Inpatients | Statisticsa | |
| Ampicillinb | 0.1 | 0.3 | n.s | 0.2 | 0.4% | n.s |
| Imipenemb | 0.2 | 0.2 | n.s | 0.2 | 0.2% | n.s |
| Ciprofloxacin | 31.6 | 45.2 | p = 0.026 | 16.1% | 33.0 | p = 0.019 |
| HLARc | 31.0 | 39.8 | n.s | 45.8% | 46.6 | n.s |
| Vancomycind | 0.0 | 0.1 | n.s | 0.1% | 0.3 | n.s |
| QP/DPe | 0.0 | 0.0 | n.s | 0.0% | 0.0 | n.s |
| Tigecycline | 0.0 | 0.0 | n.s | 0.0% | 0.0 | n.s |
| Linezolid | 0.0 | 0.0 | n.s | 0.0% | 0.0 | n.s |
aComparison of resistance levels among isolates originating from outpatients and inpatients.
bCalculated for E. faecalis isolates only.
cHigh-level aminoglycoside resistance.
dRepresents the ratio of VRE strains.
eQuinpristin/dalfopristin.
n.s. not significant (p > 0.05).